Acrivon Therapeutics, Inc. ($ACRV)
Levy Adam D. โ Chief Financial Officer
Shares
8,832
Price
$1.70
Total Value
$14,999.39
P&L
-2.3% ($338.27)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Levy Adam D. |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Jan 14, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 16, 2026 |
| Shares Purchased | 8,832 |
| Price per Share | $1.70 |
| Total Value | $14,999.39 |
| Shares Owned After | 20,983 |
| Derivative | No |
| Accession Number | 0000905148-26-000225 |
| Document | View SEC Filing |